Skip to content

Early caffeine administration prevents bronchopulmonary dysplasia of early preterm infants

Early caffeine administration prevents bronchopulmonary dysplasia of early preterm infants: a multiple RCT

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-16009243
Enrollment
Unknown
Registered
2016-09-22
Start date
2016-09-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

bronchopulmonary dysplasia

Interventions

Group A:A loading dose of caffeine (20mg/kg, 2ml of volume by IV) will be given within first 24 hours after birth followed by 10 mg/kg of daily maintain dose.
Group B:2 ml of normal saline within first 6 hours after birth. On the second day, the infant will be given a loading 2 ml dose of caffeine

Sponsors

Shanghai First Maternity and Infant Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: All preterm neonates less than 32 weeks gestational age who need respiratory support and admitted to neonatal intensive care units (NICUs) within 24 hours of age on both Shanghai First Maternal and Infant Hospital and Children's Hospital of Fudan University between September 1, 2016 and August 31, 2017.

Exclusion criteria

Exclusion criteria: The preterm neonates diagnosed perinatally with major congenital anomalies, neuromuscular disorder, metabolic diseases, severe gastroesophageal reflux, and early mortality (death on DOL 1-3) will be excluded from the study.

Design outcomes

Primary

MeasureTime frame
Incidence of BPD;Mortality;

Secondary

MeasureTime frame
Duration of mechanical ventilation;Side effect of Caffeine;

Countries

China

Contacts

Public ContactJiangqin Liu

Shanghai First Maternity and Infant Hospital

jiangqinliu@163.com+86 13482867540

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026